Jump Trading’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Jump Trading’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-26,998	Closed	-$145K	–	629
2019 Q1	$145K	Buy	+26,998	New	+$174K	0.05%	446

Other funds holding PRTK

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Jump Trading's PRTK Position: Q2 2019 in Review

Jump Trading sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2019, closing a stake of 26,998 shares — an estimated $145K sold.

Jump Trading first reported a position in PRTK in Q1 2019 and held it in 1 quarter. The position peaked at $145K in Q1 2019. 89 funds tracked by Wall St. Rank hold PRTK as of Q2 2019.

Jump Trading reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 26,998 Paratek Pharmaceuticals, Inc. shares in Q2 2019, an estimated $145K.
Jump Trading first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2019 and held it in 1 quarter.
Jump Trading's Paratek Pharmaceuticals, Inc. position peaked at $145K in Q1 2019.
89 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.